Clinical trial
Study Evaluating Safety and Immunogenicity of 13-Valent Pneumococcal Conjugate…
NCT00492557 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00492557 |
|---|---|
| Title | Study Evaluating Safety and Immunogenicity of 13-Valent Pneumococcal Conjugate Vaccine With Influenza Vaccine in Adults |
| Official title | A Phase 3, Randomized, Double-blind Trial to Evaluate Safety, Tolerability, and Immunogenicity of a 13-Valent Pneumococcal Conjugate Vaccine When Administered Concomitantly With Trivalent Inactivated Influenza Vaccine in Healthy Adults 65 Years of Age or Older, Who Are Naive to 23-Valent… |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Pneumococcal Infections |
| Intervention type | Biological |
| Interventions | 13-valent pneumococcal conjugate vaccine, 13vPnC + TIV |
| Enrollment | 1,185 |
| Start date | Sep 1, 2007 |
| Primary completion | Feb 1, 2008 |
| Completion | Feb 1, 2008 |
| First posted | Jun 27, 2007 |
| Last update posted | Feb 17, 2012 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: